Open-Label, Imaging Study of Human Corticotropin-Releasing Factor (hCRF) for The Reduction of Peritumoural Brain Oedema (PBE) in Patients With Primary Malignant or Metastatic Brain Tumours

Trial Profile

Open-Label, Imaging Study of Human Corticotropin-Releasing Factor (hCRF) for The Reduction of Peritumoural Brain Oedema (PBE) in Patients With Primary Malignant or Metastatic Brain Tumours

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Apr 2014

At a glance

  • Drugs Corticorelin (Primary)
  • Indications Brain oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Apr 2014 New trial record
    • 08 Jan 2009
    • 28 Sep 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top